Anthony Dowling

PHASE II RANDOMISED PLACEBO-CONTROLLED DOUBLE-BLIND STUDY OF ACETAZOLAMIDE VERSUS PLACEBO FOR CEREBRAL OEDEMA IN RECURRENT AND/OR PROGRESSIVE HIGH-GRADE GLIOMA REQUIRING TREATMENT WITH DEXAMETHASONE

Meera Agar, Anna Nowak, Elizabeth Hovey, Elizabeth Barnes, John Simes, Janette Vardy, Helen Wheeler, Robyn Leonard, Merryn Hall, Evonne Tim, Desma Spyridopoulos, Hao-Wen Sim, Zarnie Lwin, Anthony Dowling, Rosemary Harrup, Ross Jennens, Ganessan Kichenadasse, Tracey Dunlop, Cecelia Gzell, Eng-Siew Koh

Conference Proceedings  |  2020  |  NEURO-ONCOLOGY

Surviving glioblastoma and a sense of disconnection

L Gately, SA McLachlan, A Dowling, J Philip

Journal article  |  2020  |  JOURNAL OF CLINICAL NEUROSCIENCE

Given the poor prognosis of glioblastoma, little focus has been placed on the needs of long-term survivors (those alive at least t..

Molecular profile of long-term survivors of glioblastoma: A scoping review of the literature

L Gately, SA McLachlan, J Philip, V Rathi, A Dowling

Journal article  |  2019  |  JOURNAL OF CLINICAL NEUROSCIENCE

Molecular aberrations of malignancy are becoming widely recognized as important predictive and prognostic markers for treatment re..

Timing of brain metastases development in metastatic renal cell cancer patients treated with targeted therapies and survival outcomes: An Australian multicenter study

Francis J Ha, Lavinia Spain, Anthony Dowling, Edmond M Kwan, Carmel Pezaro, Daphne Day, Puey Ling Chia, Ben Tran, David Pook, Andrew J Weickhardt

Journal article  |  2019  |  ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY

AIM: Targeted therapy (TT) has improved survival for metastatic renal cell carcinoma (mRCC). However, survival is usually limited ..

A feasibility study of the Nativis Voyager® device in patients with recurrent glioblastoma in Australia.

Michael Murphy, Anthony Dowling, Christopher Thien, Emma Priest, Donna Morgan Murray, Santosh Kesari

Journal article  |  2019  |  CNS Oncol

AIM: Evaluation of the Nativis Voyager®, an investigational medical device, as monotherapy for recurrent glioblastoma (rGBM). MATE..

Health professionals involved in cancer care coordination: Nature of the role and scope of practice

Kerry Haynes, Anna Ugalde, Rachel Whiffen, Megan Rogers, Mary Duffy, Chris Packer, Danielle Spence, Anthony Dowling, Peter Poon, Patricia Livingston

Journal article  |  2018  |  COLLEGIAN

Background: Cancer treatment can be complex; and coordination of cancer care across different treatments and health settings is es..

The utility of routine pre-chemotherapy screening with cardiac gated blood pool scan for patients at low risk of anthracycline toxicity

Puey Ling Chia, K Chiang, R Snyder, A Dowling

Journal article  |  2018  |  JOURNAL OF ONCOLOGY PHARMACY PRACTICE

Background Anthracycline-based chemotherapy is used in many malignancies. Current recommendations by several groups suggest cardia..

Long-term survivors of glioblastoma: a closer look

Lucy Gately, Sue-Anne McLachlan, Jennifer Philip, Jeremy Ruben, Anthony Dowling

Journal article  |  2018  |  JOURNAL OF NEURO-ONCOLOGY

Glioblastoma has a poor prognosis with median survival of 12-14 months. Long-term survivors (LTS), alive at least 2 years from dia..

Life beyond a diagnosis of glioblastoma: a systematic review of the literature

L Gately, SA McLachlan, A Dowling, J Philip

Journal article  |  2017  |  JOURNAL OF CANCER SURVIVORSHIP

BACKGROUND: The median survival of glioblastoma is 12-14 months with less than 10% of patients surviving at least 2 years from dia..

Age alone is not a predictor for survival in glioblastoma

Lucy Gately, Anna Collins, Michael Murphy, Anthony Dowling

Journal article  |  2016  |  JOURNAL OF NEURO-ONCOLOGY

Over half of glioblastoma (GBM) cases are diagnosed in patients older than 65 years. Their median overall survival (OS) is 4-5 mon..